{
  "date_blocked": null, 
  "citation": {
    "state_cite_three": null, 
    "federal_cite_one": "543 U.S. 939", 
    "federal_cite_two": null, 
    "specialty_cite_one": null, 
    "federal_cite_three": null, 
    "lexis_cite": "", 
    "document_uris": [
      "/api/rest/v2/document/139563/"
    ], 
    "scotus_early_cite": null, 
    "case_name": "Andrx Pharmaceuticals, Inc. v. Kroger Co.", 
    "westlaw_cite": null, 
    "state_cite_one": null, 
    "neutral_cite": null, 
    "state_cite_regional": null, 
    "state_cite_two": null, 
    "docket_number": "03-779", 
    "id": 123916, 
    "resource_uri": "/api/rest/v2/citation/123916/"
  }, 
  "id": 139563, 
  "blocked": false, 
  "judges": "", 
  "court": "/api/rest/v2/jurisdiction/scotus/", 
  "date_filed": "2004-10-12", 
  "download_url": "http://bulk.resource.org/courts.gov/c/US/543/543.US.939.03-779.html", 
  "source": "R", 
  "local_path": null, 
  "html_lawbox": "", 
  "time_retrieved": "2010-04-28T10:32:56", 
  "nature_of_suit": "", 
  "plain_text": "", 
  "html_with_citations": "<p class=\"case_cite\"><span class=\"citation no-link\"><span class=\"volume\">543</span> <span class=\"reporter\">U.S.</span> <span class=\"page\">939</span></span></p>\n    <p class=\"parties\">ANDRX PHARMACEUTICALS, INC.<br>v.<br>KROGER CO. ET AL.</p>\n    <p class=\"docket\">No. 03-779.</p>\n    <p class=\"court\">Supreme Court of United States.</p>\n    <p class=\"date\">October 12, 2004.</p>\n    <div class=\"num\" id=\"p1\">\n      <span class=\"num\">1</span>\n      <p class=\"indent\">C. A. 6th Cir. Motions of New York Intellectual Property Law Association, Pharmaceutical Research and Manufacturers of America, Washington Legal Foundation, American Intellectual Property Law Association, and Center for the Advancement of Capitalism for leave to file briefs as <i>amici curiae</i> granted. Certiorari denied. Reported below: 332 F. 3d 896.</p>\n    </div>\n    ", 
  "sha1": "4ab037ffcad3ef153e6f0fd81d082516663538da", 
  "date_modified": "2014-12-21T02:20:49.424894", 
  "precedential_status": "Published", 
  "absolute_url": "/opinion/139563/andrx-pharmaceuticals-inc-v-kroger-co-et-al/", 
  "citation_count": 0, 
  "supreme_court_db_id": null, 
  "extracted_by_ocr": false, 
  "docket": "/api/rest/v2/docket/1501263/", 
  "html": "<p class=\"case_cite\">543 U.S. 939</p>\n    <p class=\"parties\">ANDRX PHARMACEUTICALS, INC.<br>v.<br>KROGER CO. ET AL.</p>\n    <p class=\"docket\">No. 03-779.</p>\n    <p class=\"court\">Supreme Court of United States.</p>\n    <p class=\"date\">October 12, 2004.</p>\n    <div class=\"num\" id=\"p1\">\n      <span class=\"num\">1</span>\n      <p class=\"indent\">C. A. 6th Cir. Motions of New York Intellectual Property Law Association, Pharmaceutical Research and Manufacturers of America, Washington Legal Foundation, American Intellectual Property Law Association, and Center for the Advancement of Capitalism for leave to file briefs as <i>amici curiae</i> granted. Certiorari denied. Reported below: 332 F. 3d 896.</p>\n    </div>\n    ", 
  "resource_uri": "/api/rest/v2/document/139563/"
}